Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study

´ëÇѺ´¸®ÇÐȸÁö 2011³â 45±Ç 3È£ p.254 ~ 260
±èÁø¸¸, °í¿µÇý, À̽¼÷, ÇãÁÖ·É, °­Ã¢¼®, ±èö¿ì, °­À±°æ, °íÀçÇâ, ±è¹Î°æ, ±è¿Ï¼·, ±èÀ±Á¤, ±èÇöÁ¤, ±èÈñ°æ, ³²Á¾Èñ, ¹®Çü¹è, ¹ÚÂù±Ý, ¹ÚÅÂÀÎ, ¿À¿µÇÏ, À̵¿È­, ÀÌÁ¾½Ç, ÀÌÁÖÈñ, ÀÌÇý°æ, ÀÓ¼ºÃ¶, Àå±ÔÀ±, ÀåÈñ°æ, ÀüÀ±°æ, Á¤Çý¶ó, Á¶¹Î¼±, Â÷ÈñÁ¤, ÃÖ¼®Áø, ÇÑÀçÈ£, È«¼÷Èñ, ±èÀμ±,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁø¸¸ ( Kim Jin-Man ) 
Chungnam National University College of Medicine Department of Pathology

°í¿µÇý ( Ko Young-Hyeh ) 
Samusng Medical Center Department of Pathology
À̽¼÷ ( Lee Seung-Sook ) 
Korea Cancer Center Hospital Department of Pathology
ÇãÁÖ·É ( Huh Joo-Ryung ) 
University of Ulsan College of Medicine Department of Pathology
°­Ã¢¼® ( Kang Chang-Suk ) 
Catholic University College of Medicine Department of Pathology
±èö¿ì ( Kim Chul-Woo ) 
Seoul National University College of Medicine Department of Pathology
°­À±°æ ( Kang Yun-Kyung ) 
Seoul Paik Hospital Department of Pathology
°íÀçÇâ ( Go Jai-Hyang ) 
Dankook University College of Medicine Department of Pathology
±è¹Î°æ ( Kim Min-Kyung ) 
Kangbuk Samsung Hospital Department of Pathology
±è¿Ï¼· ( Kim Wan-Seop ) 
Konkuk University College of Medicine Department of Pathology
±èÀ±Á¤ ( Kim Yoon-Jung ) 
Seoul Veterans Hospital Department of Pathology
±èÇöÁ¤ ( Kim Hyun-Jung ) 
Sanggye Paik Hospital Department of Pathology
±èÈñ°æ ( Kim Hee-Kyung ) 
Soonchunhyang University Bucheon Hospital Department of Pathology
³²Á¾Èñ ( Nam Jong-Hee ) 
Chonnam National University Medical School Department of Pathology
¹®Çü¹è ( Moon Hyung-Bae ) 
Wonkwang University School of Medicine Department of Pathology
¹ÚÂù±Ý ( Park Chan-Kum ) 
Hanyang University College of Medicine Department of Pathology
¹ÚÅÂÀΠ( Park Tae-In ) 
Kyungpook National University School of Medicine Department of Pathology
¿À¿µÇÏ ( Oh Young-Ha ) 
Hanyang University Guri Hospital Department of Pathology
À̵¿È­ ( Lee Dong-Wha ) 
Soonchunhyang University College of Medicine Department of Pathology
ÀÌÁ¾½Ç ( Lee Jong-Sil ) 
Gyeongsang National University College of Medicine Department of Pathology
ÀÌÁÖÈñ ( Lee Ju-Hie ) 
Kyung Hee University School of Medicine Department of Pathology
ÀÌÇý°æ ( Lee Hye-Kyung ) 
Eulji University School of Medicine Department of Pathology
ÀÓ¼ºÃ¶ ( Lim Sung-Chul ) 
Chosun University College of Medicine Department of Pathology
Àå±ÔÀ± ( Jang Kyu-Yun ) 
Chonbuk National University Medical School Department of Pathology
ÀåÈñ°æ ( Chang Hee-Kyung ) 
Kosin University College of Medicine Department of Pathology
ÀüÀ±°æ ( Jeon Yoon-Kyung ) 
Seoul National University College of Medicine Department of Pathology
Á¤Çý¶ó ( Jung Hye-Ra ) 
Keimyung University College of Medicine Department of Pathology
Á¶¹Î¼± ( Cho Min-Sun ) 
Ewha Womans University College of Medicine Department of Pathology
Â÷ÈñÁ¤ ( Cha Hee-Jeong ) 
University of Ulsan College of Medicine Department of Pathology
ÃÖ¼®Áø ( Choi Suk-Jin ) 
Inha University College of Medicine Department of Pathology
ÇÑÀçÈ£ ( Han Jae-Ho ) 
Ajou University School of Medicine Department of Pathology
È«¼÷Èñ ( Hong Sook-Hee ) 
Dong-A University College of Medicine Department of Pathology
±èÀμ± ( Kim In-Sun ) 
Korea University College of Medicine Department of Pathology

Abstract


Background : The aim of study was to determine the relative frequency of malignant lymphoma according to World Health Organization (WHO) classification in Korea.

Methods : A total of 3,998 cases diagnosed at 31 institutes between 2005 and 2006 were enrolled. Information including age, gender, pathologic diagnosis, site of involvement and immunophenotypes were obtained.

Results : The relative frequency of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) was 95.4% and 4.6%, respectively. B-cell lymphomas accounted for 77.6% of all NHL, while T/natural killer (T/NK)-cell lymphomas accounted for 22.4%. The most frequent subtypes of NHL were diffuse large B-cell lymphoma (42.7%), extranodal marginal zone B-cell lymphoma (MZBCL) of mucosa-associated lymphoid tissue (19.0%), NK/T-cell lymphoma (6.3%) and peripheral T-cell lymphoma (PTCL), unspecified (6.3%), in decreasing order. The relative frequency of HL was no-dular sclerosis (47.4%), mixed cellularity (30.6%), and nodular lymphocyte predominant (12.1%) subtypes. Compared with a previous study in 1998, increase in gastric MZBCL and nodular sclerosis HL, and slight decrease of follicular lymphoma, PTCL, and NK/T-cell lymphoma were observed.

Conclusions : Korea had lower rates of HL and follicular lymphoma, and higher rates of extranodal NHL, extranodal MZBCL, and NK/T-cell lymphoma of nasal type compared with Wes-tern countries. Changes in the relative frequency of lymphoma subtypes are likely ascribed to refined diagnostic criteria and a change in national health care policy.

Å°¿öµå

Lymphoma; Malignant; WHO; Korea

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS